[Use of beta adrenergic substances in the therapy of severe gestoses without endangering the child].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000438:Alcohols / Q000627:therapeutic use; D001555:Benzene Derivatives / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005313:Fetal Death / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007226:Infant Mortality; D007275:Injections, Intravenous; D008428:Maternal Mortality; D008431:Maternal-Fetal Exchange; D010636:Phenols / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000401:mortality; D011247:Pregnancy; D013566:Sympathomimetics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D000438:Alcohols; D001555:Benzene Derivatives; D001593:Benzyl Compounds; D010636:Phenols; D013566:Sympathomimetics; D014665:Vasodilator Agents
Zur Anwendung beta-adrenergischer Substanzen in der Therapie schwerer Gestosen ohne Gefährdung des Kindes.